free web maker


2020 NantKwest
Annual Meeting


Investor Materials and Voting

2019 Annual Report

View an enhanced online version of our Annual Report.

2020 Proxy Statement

View and enhanced online version of our Proxy Statement.

Vote Now

Your vote is Important! You may vote online or by phone. To vote by phone dial 866-863-3382.

Annual Meeting Details

Date:

Wednesday, June 10, 2020

Time:

9:30 a.m. PT

Virtual Meeting:


Deadline to Register*
Monday, June 8, 2020
5:00 p.m. ET

*Note: You must register by the deadline to be eligible to participate in the meeting.

FULL WIDTH INTRO

Full width intro with adjustable height, background image and a color overlay. Click any text to edit or style it.

About NantKwest, Inc.

NantKwest is an innovative clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases.

NantKwest is uniquely positioned to implement precision cancer medicine, with the potential to change the current paradigm of cancer care. Natural Killer cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. Our “off-the-shelf” activated Natural Killer (NK) platform have the capacity to destroy cancer and virally infected cells from the body. The safety of our NK cells as well as their activity against a broad range of cancers have been tested in multiple phase 1 clinical trials in the United States, Canada and Europe. In addition to our NK cells capability to be administered in the outpatient setting as an “off-the-shelf” living drug, it serves as a universal cell-based therapy without need for individualized patient matching. Moreover, our NK cell based platform has been bioengineered to incorporate chimeric antigen receptors (CARs) and antibody receptors to further optimize targeting and potency in the therapeutic disease.

To learn more visit us at www.nantkwest.com.

Powered by Mediant Communications Inc.
Copyright © 2020 Mediant Communications Inc. All Rights Reserved.